Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

NCT00390364 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to low accrual

Conditions

Colorectal Cancer

Interventions

DRUG: everolimus
PROCEDURE: antiangiogenesis therapy
PROCEDURE: biopsy
PROCEDURE: diagnostic procedure
PROCEDURE: gene expression analysis
PROCEDURE: immunohistochemistry staining method
PROCEDURE: laboratory biomarker analysis
PROCEDURE: mutation analysis
PROCEDURE: protein tyrosine kinase inhibitor therapy
PROCEDURE: reverse transcriptase-polymerase chain reaction

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]